# Effects of Fhytomenadione on Coronary Artery Calcification of Hemodialysis Patients

> **NCT04247087** · NA · COMPLETED · sponsor: **Instituto Mexicano del Seguro Social** · enrollment: 60 (actual)

## Conditions studied

- Coronary Calcification

## Interventions

- **DRUG:** phytomenadione
- **DRUG:** placebo solution

## Key facts

- **NCT ID:** NCT04247087
- **Lead sponsor:** Instituto Mexicano del Seguro Social
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-07
- **Primary completion:** 2019-09-27
- **Final completion:** 2020-01-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-01-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04247087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04247087, "Effects of Fhytomenadione on Coronary Artery Calcification of Hemodialysis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04247087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*